Cargando…
Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study
BACKGROUND: Studies reporting SBRT outcomes in oligometastatic patients with adrenal gland metastases (AGM) are limited. Herein, we present a multi-institutional analysis of oligometastatic patients treated with SBRT for AGM. MATERIAL/METHODS: The Consortium for Oligometastases Research (CORE) is am...
Autores principales: | Baydoun, A., Chen, H., Poon, I., Badellino, S., Dagan, R., Erler, D., Foote, M.C., Louie, A.V., Redmond, K.J., Ricardi, U., Sahgal, A., Biswas, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885400/ https://www.ncbi.nlm.nih.gov/pubmed/35243027 http://dx.doi.org/10.1016/j.ctro.2021.09.002 |
Ejemplares similares
-
Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease
por: Cao, Yilin, et al.
Publicado: (2021) -
Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis
por: Poon, Ian, et al.
Publicado: (2020) -
Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis
por: Chen, Xuguang, et al.
Publicado: (2021) -
Stereotactic body radiation therapy (SBRT) of adrenal gland metastases in oligometastatic and oligoprogressive disease
por: Reshko, Leonid B., et al.
Publicado: (2021) -
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)